Improving outcomes by reducing AKI in lung cancer surgery: introducing MERITS (Multi-centre Evaluation of Renal Impairment in Thoracic Surgery) (English)
- New search for: Naruka, V.
- New search for: Khushiwal, R.
- New search for: Clayton, J.
- New search for: Aresu, G.
- New search for: Peryt, A.
- New search for: Mackay, J.
- New search for: Coonar, A.
- New search for: Naruka, V.
- New search for: Khushiwal, R.
- New search for: Clayton, J.
- New search for: Aresu, G.
- New search for: Peryt, A.
- New search for: Mackay, J.
- New search for: Coonar, A.
In:
Lung cancer
;
127
, s1
;
S88
;
2019
-
ISSN:
- Article (Journal) / Print
-
Title:Improving outcomes by reducing AKI in lung cancer surgery: introducing MERITS (Multi-centre Evaluation of Renal Impairment in Thoracic Surgery)
-
Contributors:Naruka, V. ( author ) / Khushiwal, R. ( author ) / Clayton, J. ( author ) / Aresu, G. ( author ) / Peryt, A. ( author ) / Mackay, J. ( author ) / Coonar, A. ( author )
-
Published in:Lung cancer ; 127, s1 ; S88
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2019-01-01
-
Size:S88
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.99424
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.99424 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 127, Issue s1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- S1
-
Chloropyramine increases NSCLC sensitivity to cisplatin in a SASH1 dependent mannerBurgess, J. / Bolderson, E. / Adams, M. / Zhang, S. / Fox, S. / Wright, G. / Young, R. / Solomon, B. / Gray, S. / Richard, D. et al. | 2019
- S2
-
Collaborative genomics for improved patient care; a lung cancer case reportDu Parcq, P. / Harper, J. / Khorashad, J. et al. | 2019
- S3
-
National Optimal Lung Cancer Pathway implementation: can pathologists comply with turnaround times?Lloyd, K.L. / Rice, A. / Robertus, J.L. / Brambilla, C. / Popat, S. / Kemp, S. / Newsom-Davis, T. / Shah, P. / Nicholson, A.G. et al. | 2019
- S4
-
Understanding current lung cancer service to drive improvements towards achieving the national optimal lung cancer pathway at a busy district general hospitalEl-Nayal, A. / Southern, J. / Cocker, A. / Abdulla, A.C. / Aung, T. et al. | 2019
- S5
-
Reducing pathway length in lung cancer by multidisciplinary intervention: Wolverhampton Intervention in Lung cancer Daily, 'The WILD project'Morgan, A. / Berair, R. / Mathew, S. / Lakin, K. / Tanner, K. / Jones, J. et al. | 2019
- S6
-
Impact of organisation and specialist service delivery on lung cancer outcomesAdizie, J. / Khakwani, A. / Beckett, P. / Hubbard, R. / Navani, N. / Harden, S. / Woolhouse, I. et al. | 2019
- S7
-
The impact of a curative intent bundle pathway in a lung cancer serviceGlynn, P. / Tattersall, D.J. / Sayeed, N. / Menezes, B. et al. | 2019
- S9
-
Glenfield pulmonary neuroendocrine tumour guidelinesWeaver, H. / Rathinam, S. et al. | 2019
- S11
-
Implementation of National Optimal Lung Cancer Pathway: an early experienceMoneke, J. / Khan, S. / Hussain, I. et al. | 2019
- S13
-
National Optimal Lung Cancer Pathway: implementation of a 'straight to CT' pathway at NUHBakewell, F. / Hodgkiss, M. / Perumpalath, B. / Wright-Morris, D. / Severn, H. / Anwar, S. et al. | 2019
- S14
-
Initial evaluation of calcium levels of patients with suspected lung cancerApthorp, C. / Ratnakumar, S. / Warakagoda, I. / Stavrakas, N. / Crooks, S. et al. | 2019
- S15
-
CT guided percutaneous transthoracic lung biopsy (PTLB), risk of pneumothorax and associated factorsGogokhia, A. / Hawkins, S.K. / Guhaniyogi, L. / Shiels, E. / Williamson, I. / Goyal, N. / Ionescu, A.A. et al. | 2019
- S16
-
CT texture analysis as a predictor of effectiveness of second line nivolumab in metastatic non-small cell lung cancerLadwa, R. / Roberts, K. / Maggacis, N. / O'Byrne, K. / Miles, K. et al. | 2019
- S18
-
Can the recommended mediastinal staging performance standards for endosonography be met in everyday clinical practice?Barker, A. / Meek, D. / Hardy, C. / Carroll, N. / Rintoul, R. et al. | 2019
- S21
-
An evaluation of targets in lung cancer 2-week-wait pathway: closing the loop to the Quality Improvement Project at Great Western Hospital SwindonHameed, F. / Mackinlay, C. / Smith, R. / Masterman, B. / Ali, S. et al. | 2019
- S22
-
Results from a prevalence round of LDCT screening for lung cancer in the Lung Screen Uptake TrialRuparel, M. / Dickson, J. / Quaife, S. / Sophie, T. / Hall, H. / Horst, C. / Taylor, M. / Ahmed, A. / Shaw, P. / Burke, S. et al. | 2019
- S23
-
Prevalence of incidental interstitial lung disease in the Manchester lung cancer screening pilotBalata, H. / Hayton, C. / Barber, P.V. / Duerden, R. / Evison, M. / Greaves, M. / Howells, J. / Irion, K. / Karunaratne, D. / Leonard, C. et al. | 2019
- S24
-
Is tissue from stage 3 NSCLC suitable for biomarker evaluation?Smith, E. / Greystoke, A. / Iqbal, M.S. / Hanna, G. et al. | 2019
- S25
-
Do lung cancer outcomes vary by presenting symptom?Aslam, R. / Kennedy, M. / Bhartia, B. / Callister, M. et al. | 2019
- S27
-
Changes in performance status of lung cancer patients between respiratory and oncology clinicsDocherty, C. / Lin, Y.P. / Woodhouse, L. / Burke, E. / Patel, A.R.C. et al. | 2019
- S28
-
To talc or not to talc: can thoracoscopists accurately predict malignancy and trapped lung?Holme, J. / Rashed, A. / Chaudhry, A. / Mulla, A. / Wright, J. / Jackson, S. / Ahmed, M. / Evison, M. / Lyons, J. et al. | 2019
- S29
-
Indwelling pleural catheters in Fife: indications and outcomesBartlett, S. / Mackenzie, J. / Fairbairn, I. / Stevenson, M. et al. | 2019
- S30
-
Brigatinib in crizotinib-refractory ALK+ non-small cell lung cancer (NSCLC): efficacy updates and exploratory analysis of target lesion response by baseline brain lesion status in the ALTA TrialKim, D. / Huber, R. / Ahn, M. / Langer, C. / Tiseo, M. / West, H. / Groen, H. / Reckamp, K. / Hochmair, M. / Leighl, N. et al. | 2019
- S31
-
The ALK project: a real-world national network and databaseGomes, F. / Yip, K. / Tokaca, N. / Greystoke, A. / Escriu, C. / Conibear, J. / Ghosh, S. / Doherty, G.J. / Funingana, I. / Ahmad, T. et al. | 2019
- S32
-
Real-world treatment patterns among adults with treatment-naive advanced non-small cell lung (aNSCLC) cancer in Europe: a systematic literature review (SLR)Gara, A. / Varol, N. / Goring, S. / Oviedo Ovando, M. / Li, T. / Hertel, N. et al. | 2019
- S33
-
Real-world outcomes with pembrolizumab in patients with treatment-naive advanced/metastatic NSCLC in the UK: multicentre retrospective observational studyTokaca, N. / Gomes, F. / Lau, S. / Jackson, A. / Gradwell, M. / Gyi, M. / Reinius, M. / Valentine, E. / Winn, E. / Bhosle, J. et al. | 2019
- S34
-
Relationship between body mass index (BMI), body composition and outcomes in patients receiving first line chemotherapy for advanced or metastatic non-small cell lung cancer (NSCLC): a single centre experienceHolden, C. / Macmillan, C. / O'Rourke, W. / West, M. / Wootton, S. / Jack, S. / Astin, R. / Grocott, M. / Nolan, L. / Cave, J. et al. | 2019
- S35
-
Multi-modality radical intent treatment in synchronous oligometastatic non-small cell lung cancer: how many patients complete the full treatment regime recommended by the MDT?Cheng, A. / Craig, C. / Summers, Y. / Taylor, P. / Califano, R. / Cove-Smith, L. / Woolf, D. / Duerden, R. / Sharman, A. / Lyons, J. et al. | 2019
- S36
-
Use of pembrolizumab in previously treated patients with advanced non-small cell lung cancer: the Kent Cancer Network experienceHunter, S. / Angelis, V. / Shah, R. et al. | 2019
- S37
-
Real world experience of third line docetaxel ± nintedanib post-nivolumab for treatment of metastatic NSCLC in the West of ScotlandRulach, R. / Mclaren, A. / Clark, B. et al. | 2019
- S40
-
Safety of pembrolizumab in patients with non-small cell lung cancer: a real-world studyThakrar, D.B. / Essang, B. / Echlin, A. / Murdock, C. / Lind, M.J. et al. | 2019
- S41
-
Neutrophil-to-lymphocyte ratio (NLR) trends and treatment response to programmed death/ligand 1 (PD-1/PD-L1) inhibitors in non-small cell lung cancer (NSCLC)Yang, H. / Jayaprakash, K. Thippu / Aslam, S. / Jeffs, Y. / Jessop, S. / Mckay, N. / Cawood, H. / Bulusu, V.R. et al. | 2019
- S44
-
Outcome of NSCLC (non-small cell lung cancer) patients treated with second line pembrolizumab: experience from the Portsmouth Oncology CentreGyi, M.M. / Gulliford, T. / Muthuramalingam, S. et al. | 2019
- S45
-
Pembrolizumab monotherapy for advanced/recurrent non-small cell lung cancer: a Greater Manchester experienceTivey, A. / Wu, K.S. / Tay, R. / Gomes, F. / Taylor, P. / Blackhall, F. / Summers, Y. / Califano, R. / Cove-Smith, L. et al. | 2019
- S46
-
Immunotherapy outcomes based on PDL1 expression and tissue origin in NSCLCKhan, S. / Charalambous, M. / Khan, M. / Khalid, F. / Enver, M. / Ahmed, S. et al. | 2019
- S47
-
Does molecular analysis alter treatment options for patients in Wolverhampton?Jones, J. / Lakin, K. / Tanner, K. / Morgan, A. et al. | 2019
- S48
-
Does chemotherapy offer a survival benefit to NSCLC patients with a performance status of 2?Thompson, L. / Lee, C. / Burnett, A. et al. | 2019
- S49
-
An evaluation of the Irish Cancer Society's 2018 lung cancer awareness campaignMcnamara, A. / Saunders, R. / Krieger, C. et al. | 2019
- S50
-
The impact of the Lung Cancer Navigator on the MDTHugh, M. / Docksey, J. et al. | 2019
- S51
-
A retrospective 12 month audit of all lung cancer patients attending the Acute Oncology Assessment Unit at a Scottish Regional Cancer CentreDevenay, S. / Holmes, E. et al. | 2019
- S52
-
What do people living with and surviving lung cancer want and need from the Recovery Package?Roberts, J. / Tod, A. / Salim, F. / Collins, P. / Athey, V. et al. | 2019
- S53
-
Patient reported outcomes (PROs) in patients with extensive-stage small cell lung cancer receiving chemotherapy: a pilot project at a treatment tertiary oncology centreNeal, H. / Fenemore, J. / Eaton, M. / Mcentee, D. / Wray, D. / Tay, R. / Lindsay, C. et al. | 2019
- S55
-
Estimating renal function in lung cancer patientsGannon, K. / Ball, S. et al. | 2019
- S56
-
Pre-operative uptake of cardiopulmonary exercise test (CPET) in lung cancer surgery in WolverhamptonZahid, A. / Yip, K. / Pritchard, A. / Morgan, A. et al. | 2019
- S57
-
Effectiveness and tolerability of tyrosine kinase inhibitors as treatment for advanced non-small cell carcinoma (NSCLC) in the elderly: a real-world practice three-centre experienceSilva, N. / Goranov, B. / Parslow, D. / Chambers, J. / Talbot, T. / Dorey, N. / Toy, E. et al. | 2019
- S58
-
A framework for systematic clinical evaluation of technical innovations in lung cancer patients treated on the MR-linac (MRL)Cobben, D. / Bainbridge, H. / Belderbos, J. / Cheung, P. / Dubec, M. / Gomez, D. / Gore, E. / Knowles, E. / Lalezari, F. / Oelfke, U. et al. | 2019
- S59
-
Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag studyHochmair, M. / Cufer, T. / Morabito, A. / Hao, D. / Ta Yang, C. / Soo, R. / Yang, J. / Gucalp, R. / Halmos, B. / Wang, L. et al. | 2019
- S60
-
Lung cancer screening programmes: landscape in ChinaCheng, Y. / Davies, M.P.A. / Li, W. / Field, J.K. et al. | 2019
- S61
-
Pre-triage clinical questionnaire for patients on the National Optimal Lung Cancer PathwaySnook, S. / Earl, S. / Roy, A. / Daneshvar, C. et al. | 2019
- S62
-
Single-centre retrospective analysis of prognostic scores by the Royal Marsden Hospital (RMH) and the Gustave Roussy Institute (GRIm) in a Nottinghamshire population treated with immunotherapy for advanced non-small cell lung cancer (NSCLC)Lopez Escola, C. / Sheikh, O. / Franks, H. / Malton, S. / Gossage, L. / Khan, S. / Arora, A. / Hennig, I. et al. | 2019
- S63
-
Long-term follow-up of patients who had bronchial carcinoid tumours resected in a district general hospitalMccloskey, M. / Yarr, C. / Grant, K. / Doherty, M. / Sharkey, R. / Kelly, M. / Coulter, H. et al. | 2019
- S65
-
The impact of route of referral on treatment intent and survival in patients with lung cancer: results of a local surveyWoodhouse, L. / Lin, Y.P. / Burke, E. / Docherty, C. / Patel, A.R.C. et al. | 2019
- S66
-
Review of outcomes for patients with large cell neuroendocrine lung tumours in North East EnglandGault, A. / Greystoke, A. / Hughes, A. / Gardiner, J. et al. | 2019
- S67
-
Modified Lung Immune Predictive Index (mLIPI) as a predictive tool of nivolumab outcomes and immune related adverse events in advanced non-small cell lung cancer (NSCLC) patientsMoor, R. / O'Byrne, K. / Roberts, K. et al. | 2019
- S68
-
Prophylactic antibiotics following local anaesthetic thoracoscopy: do they have a role?Ahmed, M. / Jackson, S. / Lyons, J. / Evison, M. / Holme, J. et al. | 2019
- S69
-
Real-world experience with nivolumab and atezolizumab toxicities in advanced thoracic malignancies: a single centre experience in the UKChoy, J. / Chang, Y. / Newsom-Davis, T. et al. | 2019
- S71
-
Smoking patterns and attitudes to smoking cessation among patients actively receiving anti-cancer treatmentKeane, F. / Mullally, W. / Kieran, R. / O'Regan, S. / Nolan, A. / Aslan, R. / Hennessy, B. / Morris, P. / Grogan, L. / Breathnach, O. et al. | 2019
- S72
-
Outcomes after stereotactic ablative body radiotherapy for stage 1 lung cancerPhillips, I. / Chandy, E. / Yusof, H. / Lodge, D. / Bishop, L. / Mahendran, P. / Halling-Brown, M. / Saxby, H. / Ezhil, V. et al. | 2019
- S74
-
The impact of intra-thoracic anatomical changes upon the delivery of lung stereotactic ablative radiotherapyBrown, S. / Beasley, M. / Chuter, R. / Faivre-Finn, C. / Franks, K. / Henry, A. / Murray, L. / Van-Herk, M. et al. | 2019
- S75
-
Correlation of standardised uptake value (SUV) on fluorodeoxyglucose positron emission tomography scans with the development of metastatic disease in early-stage lung cancer treated with stereotactic ablative radiotherapy (SABR)Sambasivan, K. / Ahmad, S. / Hartill, C. / Smith, D. / Taylor, B. / Wilson, J. et al. | 2019
- S77
-
An audit of sequential chemoradiotherapy for non-small cell lung cancer (NSCLC) at the Leeds Cancer Centre (LCC)Sun, F. / Littlejohns, A. / Fakih, O. / Clarke, K. / Franks, K. / Snee, M. / Dickinson, P. / Jain, P. et al. | 2019
- S79
-
Patients with N3 non-small cell lung cancer (NSCLC) treated with radical chemoradiation can expect similar survival to patients with N2 diseaseGomberg, S. / Hiley, C. / Taylor, B. / Smith, D. / Ahmad, S. et al. | 2019
- S80
-
Tumour shape features are not the prognostic factors they appear to beDavey, A. / Van Herk, M. / Faivre-Finn, C. / Mistry, H. / Mcwilliam, A. et al. | 2019
- S81
-
Palliative lung radiotherapy at the Christie: audit of prescribing practice and survival analysisLewis, T. / Kennedy, J. / Price, G. / Mee, T. / Woolf, D. / Bayman, N. / Chan, C. / Coote, J. / Faivre-Finn, C. / Harris, M. et al. | 2019
- S82
-
An audit of thoracic radiotherapy in extensive stage small cell lung cancer delivered as per REST trial protocolIqbal, M.S. / Mian, A. / Bashir, S. / Haris, N. / Atherton, P. / Mcmenemin, R. / Cunnell, M. et al. | 2019
- S83
-
Determining the factors associated with 1-year survival in small cell lung cancer using national audit, chemotherapy and radiotherapy dataJones, G. / Khakwani, A. / Mckeever, T. / Hubbard, R. / Baldwin, D. et al. | 2019
- S84
-
Factors influencing treatment selection and prognosis in patients with small cell lung cancerIrshad, S. / Grove, P. / Jegannathen, A. / Hussain, I. / Bikmalla, S. et al. | 2019
- S85
-
The role of PCI in extensive stage small cell lung cancer treated with palliative chemotherapy and consolidative thoracic radiotherapyIqbal, M.S. / Mian, A. / Bashir, S. / Haris, N. / Mcmenemin, R. / Atherton, P. / Cunnell, M. et al. | 2019
- S87
-
Determining the feasibility and acceptability of a mobile health application to remotely monitor the symptoms of people with mesothelioma at homeMaguire, R. / Arber, A. / Klepacz, N. / Connaghan, J. / Mcphelim, J. / Blythe, K. / Murray, P. / Rupani, H. / Mcnaughton, L. / Moylan, A. et al. | 2019
- S88
-
Is a wedge resection a good surgical alternative to lobectomy?Burnside, N. / Zuccerelli, A. / Spence, D. et al. | 2019
- S89
-
Sheffield Prospective Single-Port VATS Quality of Life Cohort study (SP2QC)Hocknell, E. / George, H.A. / Gleeson, H.V. / Rao, J.N. / Socci, L. / Tenconi, S. / Hopkinson, D.N. / Edwards, J. et al. | 2019
- S90
-
Laser pulmonary metastasectomy preserves parenchyma: a single-institution study from the United KingdomChandarana, K. / Weaver, H. / Caruana, E. / Rathinam, S. / Nakas, A. et al. | 2019
- S91
-
Avoiding cardiac toxicity in patients undergoing curative intent radiotherapy for lung cancerBanfill, K. / Sun, F. / Mcwilliam, A. / Abravan, A. / Lilley, J. / Wheller, R. / Falk, S. / Schmitt, M. / Van Herk, M. / Franks, K. et al. | 2019
- S92
-
Rare double mutations in epidermal growth factor receptor (EGFR) mutant adenocarcinoma of lungThippu Jayaprakash, K. / Yang, H. / Aslam, S. / Jeffs, Y. / Jessop, S. / Bulusu, V.R. et al. | 2019
- S93
-
Iatrogenic tumour seeding (ITS) following a craniotomy for resection of oligometastatic non-small cell lung cancerMalek, A. / Khadka, S. / Islam, M.R. et al. | 2019
- S94
-
Rapid treatment reponse to pembrolizumab in non- small cell lung cancer (NSCLC)Plant, R. / Bayne, M. / Geldart, T. et al. | 2019
- S95
-
Experience with atezolizumab immunotherapy for a patient with non-small cell lung cancer on renal dialysisMahmood, A. / Chowdhury, S. et al. | 2019
- S96
-
Tomotherapy and tarceva: surviving ten years with stage IV lung cancerKeshwani, K. / Singer, J. / Chowdhury, S. et al. | 2019
- S98
-
Author Index| 2019
-
Do we adequately follow-up extrathoracic lesions identified on PET CT?Mendes, S. / Stockbridge, A. / Sultana, S. / Rashid, R. et al. | 2019
-
The experience of immunotherapy in lung cancer: an audit of patients receiving first-line immunotherapy for metastatic small cell lung cancer in South Tees between June 2016 and December 2017Hairudin, T. / Li, L. / Mansy, T. / Aynsley, E. / Kumar, G. / Masinghe, S. / Peedell, C. et al. | 2019
-
Treatment patterns and outcomes for limited stage small cell lung cancer treated with chemoradiotherapySim, D. / Pascoe, A. / Foweraker, K. et al. | 2019
-
Case report: station 5 nodal sampling via conventional EBUS in the presence of ROSEDeacon, A. / Rana, D. / Irion, K. / Al-Najjar, H. et al. | 2019
-
National Lung Cancer Audit patient booklet impact assessment: an evaluationRodgers, H. / Scott, O. et al. | 2019
-
Developing, launching and evaluating a research network for mesotheliomaLenny, C. / Woods, P. / Moore-Gillon, J. et al. | 2019
-
The financial impact of establishing a comprehensive inpatient smoking cessation service: developing the CURE project in Greater ManchesterMulla, A. / Shackley, D. / Pearce, C. / Howle, F. / Elsay, L. / Evison, M. et al. | 2019
-
The North Trent experience of the use of first line pembrolizumab in stage IIIB/IV non-small cell lung cancerElmushraf, R. / Clinch, H. / Salawu, A. / Fisher, P. / Young, R. / Lee, C. / Danson, S. / Bates, E. / Hatton, M. / Low, L. et al. | 2019
-
First line anti-PD1 checkpoint inhibitor in the management of patients with advanced non-small cell lung cancer: the Kent Cancer Network experienceAngelis, V. / Hunter, S. / Shah, R. et al. | 2019
-
Yield of pleural fluid cytology in those with risk factors for malignant pleural mesotheliomaTrappes-Lomax, C. / Robson, J. et al. | 2019
-
PD-L1 expression in resected non-small cell lung cancer: variation between primary tumour and nodal metastasesHaragan, A. / Gosney, J. / Field, J.K. / Davies, M. / Escriu, C. / Gruver, A. et al. | 2019
-
Defining COMMD4 as an anti-cancer therapeutic target and potential diagnostic biomarker in lung cancerSuraweera, A. / Adams, M. / Richard, D. / O'Byrne, K. et al. | 2019
-
Resection rates in patients with non-small cell lung cancer and cardiovascular co-morbiditiesWelch, C. / Adlam, D. / Peake, M. / Sweeting, M. / Rutherford, M. / Lambert, P. et al. | 2019
-
Resistance beyond osimertinibPowell, R. / Kussaibati, R. / Baijal, S. et al. | 2019
-
Age is no barrier to radical chemoradiation in locally advanced non-small cell lung cancer (NSCLC)Gomberg, S. / Hiley, C. / Taylor, B. / Ahmad, S. / Smith, D. et al. | 2019
-
Serum β-hCG in non-small cell lung cancer: a potential marker for early detection and assessing treatment response? A case reportKillean, A. / Sundaramurthy, A. / Malik, J. / Little, F. / Law, A. et al. | 2019
-
Improving outcomes by reducing AKI in lung cancer surgery: introducing MERITS (Multi-centre Evaluation of Renal Impairment in Thoracic Surgery)Naruka, V. / Khushiwal, R. / Clayton, J. / Aresu, G. / Peryt, A. / Mackay, J. / Coonar, A. et al. | 2019
-
Survival following radical radiotherapy for satellite or synchronous ipsilateral nodulesWalls, G. / Hanna, G. / Young, L. / Kearney, B.O. / Harney, J. / Eakin, R. / Mcaleese, J. et al. | 2019
-
Gross tumour volume (GTV) delineation on magnetic resonance imaging (MRI), for stage III lung cancer: consensus recommendations needed to ensure contouring consistencyShiarli, A. / Brown, S. / Dubec, M. / Bainbridge, H. / Koh, D. / Lalezari, F. / Van Herk, M. / Wetscherek, A. / Knowles, E. / Faivre-Finn, C. et al. | 2019
-
Stereotactic ablative radiotherapy for second primary lung malignancy arising post-pneumonectomyAriyaratne, H. / Chander, A. / Anderson, A. / Pasciuti, K. / Cooper, E. et al. | 2019
-
Management recommendations of the lung cancer MDT: are they being followed?Anderson, V. / Doe, S. / Ward, A. et al. | 2019
-
Patient characteristics, imaging and treatment of lung carcinoids in a large teaching hospitalAbi Musa Asa'Ari, A.K.A. / Iftikhar, S. / Niazi, M. / Ghosh, S. / Abid, Q. / Satur, C. / Van Pittius, D. Gey / Hussain, I. / Khan, S. / Haris, M. et al. | 2019
-
Usage and knowledge of electronic cigarettes (e-cigs) in young people in ManchesterHarris, M. / Coote, J. / Blank, M. / Girling, I. et al. | 2019
-
PRO-CTCAE vs REQUITE: a comparison of two patient reported outcome (PRO) measurement tools in a lung cancer populationJordan, T. / Califano, R. / Coote, J. / Falk, S. / Harris, M. / Mistry, H. / Taylor, P. / Woolf, D. / Faivre-Finn, C. et al. | 2019
-
The experience of immunotherapy in lung cancer: an audit of immunotherapy use as second-line treatment for metastatic non-small cell lung cancer (NSCLC) in the South Tees regionHairudin, T. / Li, L. / Mansy, T. / Aynsley, E. / Kumar, G. / Masinghe, S. / Peedell, C. et al. | 2019
-
Outcomes for patients with NSCLC on immunotherapy treatment (adenocarcinoma)Khalid, F. / Weston, C. / Enver, M. / Khan, S. / Ahmed, S. et al. | 2019
-
Optimising management of EGFR mutant NSCLC through circulating tumour DNA (ctDNA) monitoringPowell, R. / Kussaibati, R. / Baijal, S. et al. | 2019
-
Real world treatment and outcomes in patients with EGFR mutation positive advanced non-small cell lung cancer: the Kent Cancer Network experienceAngelis, V. / Fenton, M. / Hunter, S. / Shah, R. et al. | 2019
-
A single centre experience of first-line pembrolizumab in stage IV non-small-cell lung cancer (NSCLC)Denslow, R. / Yarde, A. / Brunner, C. / Walther, J. / Botten, J. / Jankowska, P. et al. | 2019
-
Implementing a low-dose CT screening programme for lung cancer into routine NHS practice: the South Tyneside ModelRoss, T. / Athey, S. / Hunter, J. / Fuller, E. et al. | 2019
-
Does pleural fluid volume influence adequacy of samples for immunohistochemistry or molecular testing?Mccracken, D. / Mercer, R. / Bedawi, E. / Hassan, M. / Asciak, R. / Rahman, N. et al. | 2019
-
Human single-stranded DNA protein 1 (hSSB1): a prognostic factor and target for non-small cell lung cancer (NSCLC) treatmentBoucher, D. / Ashton, N. / Suraweera, A. / Burgess, J. / Bolderson, E. / Barr, M. / Gray, S. / Gately, K. / Adams, M. / Croft, L. et al. | 2019
-
One size doesn't fit all. Arguments for and against pathway redesign in a small District General Hospital (DGH) to accommodate the National Optimal Lung Cancer PathwayBolton, S. / Taylor, C. / Webb, A. et al. | 2019
-
Firming up on pulmonary nodules: a nurse-led approachGraves, J. / Hillcox-Smith, A. / Burnham, A. et al. | 2019
-
Stereotactic ablative radiotherapy for non-small cell lung cancer: early experience in Aberdeen Royal InfirmaryLaws, K. / Duncan, A. / Tan, W.W. / Stilwell, C. / Moleron, R. et al. | 2019
-
Lung cancer in the young: an Irish case seriesPeters, N. / Lucas, M. / Sui, J. / Maceochagain, C. / Mcmorrough, D. / Ryan, A.B. / Ryan, B. / Mccaffrey, J. / Carney, D. / Higgins, M. et al. | 2019
-
The impact of community-based lung cancer screening on smoking behaviour in a deprived populationTraverse-Healy, L. / Balata, H. / Blandin Knight, S. / Armitage, C.J. / Barber, P.V. / Colligan, D. / Elton, P. / Kirwan, M. / Lyons, J. / Mcwilliams, L. et al. | 2019
-
An assessment of the impact of smoking and comorbid conditions on lung cancer outcomesBurke, E. / Docherty, C. / Lin, Y.P. / Woodhouse, L. / Patel, A.R.C. et al. | 2019
-
Missing the boat: real world analysis of second line osimertanib use across North West LondonEvans, J. / Sita-Lumsden, A. / Black, J. / Mackay, K. / Bendle, M. / Hatcher, O. / Power, D. / Newsom-Davis, T. et al. | 2019
-
Cells and DNA: quality improvement (QI) initiative for molecular tests from cytology samplesBhagwat, P. / Du Parcq, P. / Khorashad, J. / Harper, J. et al. | 2019
-
Brain imaging prior to radical radiotherapy for NSCLCClosier, P. / Cox, R.A. / Frim, O. et al. | 2019
-
Human single-stranded DNA protein 1 (hSSB1): a new prognostic tool and target for non-small cell lung cancer treatmentBoucher, D. / Ashton, N. / Suraweera, A. / Burgess, J. / Bolderson, E. / Barr, M. / Gray, S. / Gately, K. / Adams, M. / Richard, D. et al. | 2019
-
Multiplex PCR testing of diagnostic lung cancer tissue samples for commonly mutated oncogenesSnead, D.R. / Thomas, M. / Nyoni, J. / Wotherspoon, T. / Cree, I.A. et al. | 2019
-
Outcomes for patients with NSCLC on immunotherapy treatment (squamous)Khan, M. / Weston, C. / Charalambous, M. / Khan, S. / Ahmed, S. et al. | 2019
-
Audit of outcomes of patients with stage III NSCLC (TNM VII) who were treated with radical RT or high-dose palliative radiotherapy between January 2017 and July 2017Smith, E. / Aynsley, E. / Kumar, G. / Peedell, C. / Masinghe, S. et al. | 2019
-
Video-assisted thoracoscopicsurgical procedures using laryngeal mask (LMA) spontaneous ventilation anaesthesia: an early experience of a novel anaesthetictechniqueHussain, A. / Ayiomamitis, M. / Isaac, E. / Tentzeris, V. / Chaudhry, M. / Loubani, M. / Qadri, S. et al. | 2019
-
A case of hyperprogression of lung cancer following atezolizumabMuthukumar, D. / Saunders, E. / Rubasingham, J. / Nagarajah, V. et al. | 2019
-
Pembrolizumab in non-small cell lung cancer: our experienceRizvi, S.A. / Reza, S. / Kabba, T. / Ajzensztejn, D. / Dwyer, M. / Randhawa, R. / Karina, M. et al. | 2019
-
Editorial Board| 2019
-
Neuroendocrine cells in the lung: physiology and pathologyPink, G. / Mapfunde, I. / Lara, B. et al. | 2019
-
Early proactive referral identifies lung cancer patients with significant palliative care needsDroney, J. / Kano, Y. / Nevin, J. / Kamal, L. / Kennett, A. / Oloko, R. / Popat, S. / Wiseman, T. / Wood, J. / Stevens, A. et al. | 2019
-
Development of a lung consultant therapy radiographer and the impact on the stereotactic ablative radiotherapy pathway: the Northern Centre for Cancer care (NCCC) Newcastle experiencePickles, R. / Driver, S. / Atherton, P. / Iqbal, M.S. et al. | 2019
-
Lung cancer stigma: addressing it in clinical careMaguire, R. / Lewis, L. / Mcphelim, J. / Cataldo, J. / Milroy, R. / Wood, K. / Perham, M. et al. | 2019
-
Early experience from the Plymouth National Optimal Lung Cancer PathwaySnook, S. / Gunaratne, H. / Probyn, B. / Nicholson, T. / Corcoran, J.P. / Waine, D.J. / Howell, T.J. / Riordan, R. / Roy, A. / Daneshvar, C. et al. | 2019
-
A project to investigate and compare biopsy methods for lung cancer diagnosisPink, G. / Drought, J. / Yap, W.H. / Wu, J. et al. | 2019
-
Analysis of cytomorphology in NSCLC with specific epidermal growth factor (EGFR) mutationsBowden, R. / Al-Najjar, H. / Narine, N. / Shelton, D. / Wallace, A.J. / Bailey, S. / Karunaratne, D. / Rana, D. et al. | 2019
-
Assess the benefits of Implementing regular nutritional screening for patients with a lung cancer diagnosisRushton, C. / Anderson, V. / Walton, A. et al. | 2019
-
Toxicities and acute oncology service demand of patients receiving immunotherapy for NSCLC: single centre experienceClosier, P. / Sephton, M. / Cox, R.A. et al. | 2019
-
Smoking cessation: an important, simple and yet forgotten intervention!Hamigi, I. / Muneer Ahmed, S. / Khan, S. et al. | 2019
-
Lung adenocarcinoma with ROS1 rearrangement presenting with bilateral organizing pneumonia: a case reportAslam, S. / Jeffs, Y. / Jessop, S. / Collins, S. / Azher, M. / Thomas, E. / Gillespie, L. / Barclay, C. / Vohra, V. / Maidment, G. et al. | 2019
-
Large thoracic mass: an unsual presentation of Hodgkin's lymphomaNiazi, M. / Irshad, S. / Haris, M. et al. | 2019
-
Concurrent chemoradiation in limited stage small cell lung cancer (LS-SCLC): an analysis of survival and toxicityMatthews, S. / Iqbal, M.S. / Mcmenemin, R. / Atherton, P. / Mulvenna, P. / Kovarik, J. / Simmons, T. / Singhal, S. / Mcdonald, F. / Turnbull, H. et al. | 2019
-
Short versus long course of palliative radiotherapy for symptom control irradiating chest in lung cancer patientsBelikova, H. / Hicks, J. et al. | 2019
-
Acute radiation induced CT changes after stereotactic ablative body radiotherapy for primary non-small cell lung cancerSaxby, H. / Chandy, E. / Phillips, I. / Prakash, V. / Ezhil, V. et al. | 2019
-
Experience of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC): an analysis of treatment response and survival outcomeIqbal, M.S. / Pickles, R. / Mackenzie, L. / Burns, A. / Turnbull, H. / Atherton, P. et al. | 2019
-
Real world practice patterns for NSCLC patients in an Irish setting: a multi-centre study on targetable gene alterations and PD-L1 expressionKee, W. / Mullally, W. / Dennehy, C. / Greene, J. / Kelly, D. / Bambury, R. / Bird, B. et al. | 2019
-
Medical thoracoscopy in a DGH: 1-year activityMackenzie, J. / Fairbairn, I. / North, F. / Quirie, C. et al. | 2019
-
Trustwide audit of percutaneous lung biopsy (PLB): delays and complication ratesPegg, E. / Maddock, M. / Slaney, P. / Elliott, S. / Wilson, P. et al. | 2019
-
University Hospitals North Midlands outcomes from sequential chemo-radiotherapy in non-small cell lung cancerBest, J. / Giridharan, S. et al. | 2019
-
A local qualitative study exploring facilitators and barriers to effective lung cancer decision makingAdizie, J. / Kadiri, S. / Ismail, I. / Woolhouse, I. / Turner, A. et al. | 2019
-
Clinical outcomes related to smoking status in the era of single-port VATS resection for non-small cell lung cancerGleeson, H.V. / George, H.A. / Hocknell, E. / Rao, J.N. / Socci, L. / Tenconi, S. / Hopkinson, D.N. / Edwards, J.G. et al. | 2019
-
An audit into the use of bisphosphonates for patients with non-small cell lung cancer and bone metastases at a tertiary cancer centreBroadbent, R. / Lindsay, C. / Blackhall, F. et al. | 2019
-
A single centre experience of anti-PDL1 and anti-PDL agents in the treatment of thoracic malignanciesChoy, J. / Chang, Y. / Newsom-Davis, T. et al. | 2019
-
Managing elderly patients with lung cancer: is there a need for onco-geriatrics?Brunner, C. / Bennett, S. / Jankowska, P. et al. | 2019
-
Understanding patients' psychological responses to low-dose CT lung cancer screening to inform the development of a training resource for nursesKummer, S. / Waller, J. / Ruparel, M. / Mcewen, A. / Janes, S. / Quaife, S. et al. | 2019
-
Improving the assessment of cardiovascular and respiratory risk factors in radically treated non-small cell lung cancer (NSCLC) using quality improvement methodologyRobinson, S. / Liu, W. / Anand, G. et al. | 2019
-
Managing osteonecrosis of the jaw related to denosumab in patients with lung cancerWenban, C. / Mitchell, L. / Khan, S. / Ahmed, S. et al. | 2019
-
Lung cancer 2-week wait referrals, implentation of a new serviceSmith, R. / Galt, J. et al. | 2019
-
Preoperative mediastinal staging throughout Northern IrelandKhan, R. / Burnside, N. et al. | 2019
-
The benefits of web-based clinician-led daily tracking of lung cancer diagnostic pathwaysGrundy, S. / Taylor, M. / Kelly, P. / Hyde, P. / Macdougall, M. et al. | 2019
-
Banf1 as a marker of lung cancer cell sensitivity to cisplatinPlowman, J. / Bolderson, E. / Burgess, J. / Richard, D. / O'Byrne, K. et al. | 2019
-
Hypofractionated radiotherapy with chemotherapy for stage 3 non-small cell lung cancer: a single centre experiencePatibandla, A. / Mohammed, N. / Brisbane, I. / Mcloone, P. / Hicks, J. et al. | 2019
-
An audit on IASLC compliance of lymph nodes dissection and impact on survival after surgery for non-small cell lung cancerDe Sousa, P. / Mansour, F. / Barbosa, M. / Booth, S. / Klein, H. / Mani, A. / Nizami, M. / Von Crease, C. / Kyparissopoulos, D. / Townsend, E. et al. | 2019
-
The tsunami that is immunotherapy in NSCLCCharalambous, M. / Weston, C. / Khan, M. / Khan, S. / Ahmed, S. et al. | 2019
-
Nail toxicity in a patient being treated with immune checkpoint inhibitorsBotten, J. / Jankowska, P. / Walther, J. / Yarde, A. et al. | 2019
-
Overall survival (OS) of real-world patients with stage IIIb/IV non-small cell lung cancer (NSCLC) initiating epidermal growth factor receptor (EGFR) targeted tyrosine kinase inhibitors (TKI) as first-line treatment in EnglandRigney, U. / Lock, K. / Chen, C. / Escriu, C. et al. | 2019
-
A retrospective comparison of frontline platinum in non-squamous non-small-cell lung cancer in North Wales over 9 yearsWreglesworth, N. / Chauhan, M. / Fuller, C. / Mullard, A. / Bale, C. / Roberts, C. / Innominato, P. et al. | 2019
-
Mesothelioma in women: a retrospective case note audit of the occupational history of women diagnosed with malignant mesothelioma in a DGH 2012–2017Moylan, A. / Squibb, L. et al. | 2019
-
EBUS-TBNA for the diagnosis of lung parenchymal lesionsSingh, R. / Lal, A. et al. | 2019
-
Are endobronchial ultrasound-guided transbronchial needle aspiration samples adequate for PD-L1 testing in non-small cell lung cancer?Falconer, W. / Bhatt, N. / Medford, A. et al. | 2019
-
Implementation of the National Optimal Lung Cancer Pathway: the Nottingham experienceBakewell, F. / Hodgkiss, M. / Nair, A. / Kennedy, C. / Szolin, S. / Perumpalath, B. / Baldwin, D. / Anwar, S. et al. | 2019
-
Enhancing sensitivity to platinum-based therapy by suppressing the novel prognostic factor CDCA3 in non- small cell lung cancerAdams, M. / Burgess, J. / Richard, D. / O'Byrne, K. et al. | 2019
-
Triage of suspected cancer referrals as part of the National Optimal Lung Cancer Pathway (NOLCP): is this acceptable to patients?Brackenborough, K. / Downes, A. / Ivey, S. / Gabriel, L. / Abed El Khaleq, Y. / Powell, H. et al. | 2019
-
A survey of the practice of stereotactic ablative radiotherapy for lung cancer in the UK on behalf of the Advanced Radiotherapy Technologies Network (ART-NET)Brown, S. / Beasley, M. / Mcnair, H. / Faivre-Finn, C. / Henry, A. / Van-Herk, M. et al. | 2019
-
Engaging with the National Optimal Lung Cancer Curative Intent Management Pathway: the Bristol experienceTeh, E. / Low, A. / Casali, G. / West, D. et al. | 2019
-
Volumetric analysis for pulmonary nodules surveillance: a retrospective auditRowan, C. / Farmer, N. / Exley, C. / Ameri, A. et al. | 2019
-
Single centre real life experience with first line pembrolizumab in advanced NSCLC in the North West Coast (Lans and South Cumbria)Abdulwahid, D. / Abutaleb, K. / Mirza, A. et al. | 2019
-
Audit of stage III non-small cell lung cancer (NSCLC) management in the Essex Cancer NetworkReinius, M. / Malek, A. / Powrie, D. / Yung, B. / Ingle, C. / Islam, M.R. / Dancey, G. et al. | 2019
-
A review of urgent suspected lung cancer referrals in Edinburgh Royal InfirmaryQuinn, T. / Skwarski, K. et al. | 2019
-
Peptide receptor radionuclide therapy for metastatic bronchopulmonary carcinoid tumours: a single ENETS Centre of Excellence experienceEvans, J. / Yang, W.M. / Newsom-Davis, T. / Sharma, R. et al. | 2019
-
Efficacy and safety of systemic treatment for older lung cancer patientsGandhi, R. / Kussaibati, R. / Powell, R. / Baijal, S. et al. | 2019
-
Clinical presentation and prognosis of high PD-L1 expressors in non-small cell lung cancerChin, I.S. / Yip, K.P. / Middleton, G. et al. | 2019
-
Psychological impact of low-dose CT screening in a 'real-world' demonstration lung cancer screening pilotKummer, S. / Waller, J. / Ruparel, M. / Janes, S. / Quaife, S. et al. | 2019
-
Achieving the National Optimal Lung Cancer Pathway: the role of the biomedical scientistRicketts, W. / Giaslakiotis, K. / Jeetle, S. / Wong, A. / Sheaff, M. et al. | 2019
-
Should smoking cessation be promoted in patients with advanced lung cancer: a literature reviewHugh, M. et al. | 2019
-
Acute kidney injury risk and prevention in patients undergoing treatment for lung cancerLewis, A. / Ladan, Z. / Al-Sayed, T. / Campbell, G. / Blackhall, F. et al. | 2019
-
Impact of radiographer immediate reporting of chest x-rays from general practice on the lung cancer pathway (radioX)Woznitza, N. / Devaraj, A. / Janes, S. / Duffy, S. / Rowe, S. / Bhowmik, A. / Maughn, S. / Piper, K. / Baldwin, D. et al. | 2019
-
EBUS in lung cancer staging and diagnosis: service performance across a cancer allianceMulla, A. / Al-Najjar, H. / Bailey, S. / Brown, L. / Martin, J. / Lyons, J. / Crosbie, P.A.J. / Booton, R. / Evison, M. et al. | 2019
-
Follow-up post lung cancer surgery; is there still a role for routine chest radiographs after completion of surveillance CT scans?Rowan, C. / Mccarthy-Bell, K. / Blaxill, P. / Ameri, A. et al. | 2019
-
CT as a tool for endobronchial stent size estimation: a district general hospital experienceSundaralingam, A. / Wilkinson, J. / Sharma, N. et al. | 2019
-
Liverpool Healthy Lung Project second year evaluation: deaths prevented and significant other findingsHill, S. / Ledson, M. / Grundy, S. / Gaynor, E. / Fidoe, D. / Mason, S. / Field, J.K. / Duffy, S. et al. | 2019
-
Immune-related adverse events in patients with stage IV non-small cell lung cancer on immunotherapy: experience from the West of ScotlandDownham, E. / Maclaren, V. / Mcloone, P. et al. | 2019
-
MARS-2 trial of extended pleurectomy/decortication for malignant mesothelioma: outcomes of screening groups from a surgical centreSharkey, A. / Broomes, N. / Socci, L. / Tenconi, S. / Stanley, H. / Hanratty, H. / Matthews, S. / Fisher, P. / Edwards, J. et al. | 2019
-
DGH experience of implementing NOLCP: day –3 to 0Spencer, E. / Ward, M. / Hugh, M. / Docksey, J. / Gill, C. et al. | 2019
-
PD-L1 testing in advance stage lung cancer using cytology samples: suitability and interobserver agreement. How well are we doing?Elshiekh, M. / Iles, S. / Hopcroft, D. / Trivedi, P. / Gupta, N. / Bhagwat, P. / Viola, P. et al. | 2019
-
Diagnostic yield and safety of EBUS-TBNA: single-centre experience of 500 patientsBaty, N. / Singh, R. / Lal, A. et al. | 2019
-
The utility of cfDNA as a diagnostic tool in the management of EGFR-mutated non-small cell lung cancer (NSCLC): our regional off-study experienceNageshwaran, S. / Ping, B. / Mehta, A. / Ezhil, V. / Feng, G. / Hall, J. / Shaheed, M. / Amin, N. / Faulkes, C. / Collins, N. et al. | 2019
-
An audit of pulmonary nodule workload and a proposed pathway in response to the recent BTS guidelinesWebb, P. / Rhodes, A. et al. | 2019
-
Evaluating an intervention to improve the two-week wait pathway times for patients with radiologically suspected lung cancers in a district general hospitalDexter, L. / Price, L. / Graves, J. et al. | 2019
-
Metachronous oligometastatic non-small cell lung cancer: are we selecting the appropriate patients for radical treatment?Cheng, A. / Craig, C. / Summers, Y. / Taylor, P. / Califano, R. / Cove-Smith, L. / Woolf, D. / Duerden, R. / Sharman, A. / Lyons, J. et al. | 2019
-
Testing of EGFR mutations, ALK translocations and PD-L1 expression in patients diagnosed with adenocarcinoma at Great Western Hospital, Swindon: a re-audit after reflex testing had been declinedGibson, V. / Khan, O. et al. | 2019
-
Optimising nodule management with data from the Lung Screen Uptake TrialHorst, C. / Ruparel, M. / Dickson, J. / Quaife, S. / Hall, H. / Tisi, S. / Taylor, M. / Ahmed, A. / Shaw, P. / Burke, S. et al. | 2019
-
Performance of endobronchial ultrasound-guided transbronchial needle aspiration in PD-L1 testing in patients with NSCLCPerrotta, F. / Nankivell, M. / Adizie, J. / Elshafi, M. / Jafri, S. / Maqsood, U. / Munavvar, M. / Woolhouse, I. / Lerner, A. / Evison, M. et al. | 2019
-
Radiological-pathological correlation of negative CT biopsy results enables high negative predictive value for thoracic malignancyBarnett, J. / Pulzato, I. / Padley, S. / Jordan, S. / Nicholson, A.G. / Rice, A. / Choraria, A. / Javed, M. / Lee, Y.J. / Kemp, S. et al. | 2019
-
Comparing outcomes of patients with epidermal growth factor receptor (EGFR) therapy resistant mutations (EXON 20 and T790M)Enver, M. / Khalid, F. / Khan, S. / Ahmed, S. et al. | 2019
-
The impact of COPD on lung cancer treatment and survivalLin, Y.P. / Docherty, C. / Burke, E. / Woodhouse, L. / Patel, A.R.C. et al. | 2019
-
An audit on the outcomes of patients with primary lung cancer treated with stereotactic ablative radiotherapy (SABR) at a single institute between 2013 and 2018Mccabe, A. / Foweraker, K. / Pascoe, A. et al. | 2019
-
SABR implementation at a regional cancer centre: first-year outcomes and challenges at the Kent Oncology CentreForner, S. / Cominos, M. / Brown, J. / Burcombe, R. / Hall, J. / Hadaki, M. / Brulinski, P. / Sevitt, T. et al. | 2019
-
One-year survival data for lung cancer at the Princess Alexandra NHS TrustAghadiuno, T. / Keshwani, K. / Wasin, Z. / Papadatos-Pastos, D. / Chowdhury, S. et al. | 2019
-
Intratumoral heterogeneity in PD-L1 expression in pleomorphic lung carcinoma: implications for management of stage III diseaseJanuszewski, A. / Chang, W. / Zhang, Y.Z. / Laggner, U. / Bowman, A. / Adefila-Ideozu, T. / Moffatt, M. / Cookson, W. / Nicholson, A.G. / Popat, S. et al. | 2019
-
Radical radiotherapy alone versus chemoradiotherapy for the treatment of stage III (N2) non-small cell lung cancerMcaleese, J. / Tumelty, K. / Gillott, C. / Eakin, R. / Harney, J. / Young, L. / Walls, G. / Hanna, G. et al. | 2019
-
A retrospective analysis of lymphopenia rates during and after sequential and concurrent radical chemoradiotherapy for patients with stage III non-small cell lung cancer (NSCLC)Westley, R. / Philipps, L. / Lock, I. / Ahmed, M. / Mcdonald, F. et al. | 2019
-
Evaluation of potential implementation of proposed 28-day cancer waiting time standard at Oxford University Hospitals NHS Foundation TrustGalante, J.R. / Shaw, A. / Gandhi, S. / Harrogate, E. / Sykes, A. et al. | 2019
-
Implementation of network-wide mesothelioma MDT and the effect on patient outcomesHobden, D. / Powrie, D. / Yung, B. / Dancey, G. / Mediros, F. / Muthukumar, D. / Lawson, M. et al. | 2019
-
Attitudes to, and symptom awareness of lung cancer in Ireland: findings from a global consumer pollMcnamara, A. / O'Hagan, K. / Deegan, A. et al. | 2019
-
Developing a nurse consultant-led immunotherapy services in a district general hospitalMuthukumar, D. / Sheen, L. / Rubasingham, J. / Saunders, E. et al. | 2019
-
A single centre experience of anti-PDL1 and anti-PD1 agents in treatment of non-small cell lung cancer (NSCLC)Saunders, E. / Rubasingham, J. / Muthukumar, D. / Ingle, C. et al. | 2019
-
Radial endobronchial ultrasound for the diagnosis of malignant peripheral pulmonary lesions deemed unsuitable for percutaneous CT guided biopsy in a regional 'Difficult Thoracic Biopsy' serviceTariq, S. / Balata, H. / Martin, J. / Lyons, J. / Crosbie, P.A.J. / Booton, R. / Evison, M. et al. | 2019
-
Analysis of patients referred to lung cancer MDM due to diagnosis of lung cancer made during an acute emergency admission in South Eastern HSC TrustJamaludin, J. / Bailey, M. / Rowan, S. et al. | 2019
-
Evidence-based best practices for EGFR and EGFR T790M mutation testing in non-small cell lung cancer (NSCLC) in the UKWelch, L. / Butler, R. / Taniere, P. / Thompson, L. / Oniscu, A. / Clarke, C. / Burghel, G. / Collins, N. / Timm, L. et al. | 2019
-
Does endobronchial ultrasound (EBUS) fine needle aspirate provide sufficient tissue for molecular markers?Gabriel, L. / Brackenborough, K. / Higton, A. / Hughes, N. / Macintyre, J. / Powell, H. et al. | 2019
-
Establishing a clinical sequencing program for lung cancer in a public hospitalO'Byrne, K. / Leo, P. / Ellis, J. / Clout, M. / Mcinerney-Leo, A. / Wheeler, L. / Anderson, L. / Brown, M. et al. | 2019
-
Quality outcome measures for single-port VATS resection of non-small cell lung cancerGeorge, H.A. / Gleeson, H.V. / Hocknell, E. / Rao, J.N. / Socci, L. / Tenconi, S. / Hopkinson, D.N. / Edwards, J.G. et al. | 2019
-
Retrospective analysis of the management of extensive stage small cell lung cancer (SCLC) in patients with a poor performance statusMoore, T. / Gossage, L. / Lopez Escola, C. / Hennig, I. et al. | 2019
-
Patient-reported outcome measures for lung cancer in daily clinical useDavies, G. / Collier, G. / Whatling, K. et al. | 2019
-
A retrospective case-control study to assess the impact of enhanced supportive care for patients with advanced lung cancerVijeratnam, N. / Stockley, A. / Godfrey, N. / Jenkins, E. / Dorey, N. / Toy, E. et al. | 2019
-
Improving psychological support for patients with lung cancer and mesothelioma: evaluation of three new nurse-led servicesIvey, S. / Partridge-James, T. / Powell, H. / Mehta, A. et al. | 2019
-
Lung cancer pathway: first consultation patient information leafletCanning, L. / Sparkes, H. / Al-Najjar, H. et al. | 2019
-
The value of the lung cancer nurse specialist in the development and implimentation of the local optimal lung cancer pathwayBennett, A. / Patrick, C. et al. | 2019
-
An audit on the use of osimertinib in T790M EGFR+ patients at West Suffolk HospitalDavis, O. / Patterson, D. / Martin, A. et al. | 2019
-
Is the current strategy for stratifying patients for targeted therapy use in NSCLC really logical and sustainable? Results from a retrospective study suggest otherwiseMoore, D. / Maddox, A. / Gillibrand, R. / Medeiros, F. et al. | 2019
-
Can 'Upfront' PET-CT reduce time to diagnosis in lung cancer target referrals?Verghese, P. / Elsheikh, A. / Mo, J. / Jain, S. / Powrie, D. et al. | 2019